SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-18-001084
Filing Date
2018-11-27
Accepted
2018-11-27 14:21:23
Documents
2
Period of Report
2018-11-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1603
2 torti_poa.htm EX-24 7132
  Complete submission text file 0001123292-18-001084.txt   10226
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2855 SAND HILL ROAD MENLO PARK CA 94025
Business Address
Torti Frank (Reporting) CIK: 0001647805 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34949 | Film No.: 181202824